Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 12, 2026 04:00 ET | Source: Cbio A/S

Cbio A/S Receives European Regulatory Clearance to Begin First-in-Human Clinical Trial of Next-Generation T-Cell Therapy in late-stage Cervical Cancer

Cbio gets EMA approval to start its phase I/IIa clinical trial in late stage cancer patients with novel T-cell product armored against oxidative stress